AGICC network

The Asian Gastrointestinal Cancer Consortium (AGICC) is a premier clinical research network dedicated to advancing the treatment of gastrointestinal (GI) cancers through collaborative trials across Asia. Established in 2013, the consortium links leading academic medical centers in South Korea, Japan, China, Taiwan, and Singapore to address the high regional burden of GI malignancies. AGICC facilitates both investigator-initiated research and large-scale industry-sponsored clinical trials, providing a robust infrastructure for multi-center studies. The organization focuses on identifying unique biomarkers and developing precision medicine strategies specifically for Asian patient populations. Notable achievements include leading pivotal trials for checkpoint inhibitors and targeted therapies in gastric and esophageal cancers. By standardizing research protocols and leveraging a vast patient network, AGICC continues to shape the global standard of care for GI oncology.